Abbott Laboratories (ABT) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Abbott Laboratories  (NYSE: ABT)


Abbott Laboratories's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Abbott Laboratories's ROI in the third quarter of 2026?
Abbott Laboratories achieved a return on average invested assets (ROI) of 5.61 % in its third quarter of 2026, which is below Abbott Laboratories's average return on investment, which stands at 10.18%.

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 74 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 1020, from total ROI ranking in the second quarter of 2026 at 1063.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 31.21 % 24.58 % 18.51 % 14.57 % 18.36 %
Y / Y Net Income Change TTM -66.37 % -61.19 % -48.56 % -40.01 % 749.15 %
Investment (TTM) in Millions 92,691 92,053 82,979 67,761 63,170
Return On Investment (TTM) 5.61 % 7.09 % 9.03 % 10.15 % 21.87 %
ABT's Overall Ranking # 1020 # 1063 # 313 # 281 # 304
Seq. Investment Change TTM 9.65 % 10.09 % 8.14 % 0.52 % 4.11 %
Seq. Net Income Change TTM -13.35 % -13.56 % -3.8 % -53.32 % -0.01 %
Net Income (TTM) in Millions 4,701 5,425 6,276 6,524 13,977

ABT Company Profile >> Back to ABT Roi Comparisons >> See Annual ABT Return On Investment



Return On Investment ABT's Ranking
Within: No.
Industry # 22
Sector # 75
Overall # 1020

Return On Investment Statistics
High Average Low
21.06 %
10.18 %
0.73 %
(Dec 31 2024)   (Dec 31 2017)







Financial Statements
Abbott Laboratories's III. Quarter Investments $ 92,691 Millions ABT's Balance sheet
Abbott Laboratories's III. Quarter Income $ 920 Millions Quarterly ABT's Income Statement
ABT's Income by Division See ABT's Income by Division


ABT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 67,761 66,441 58,143 51,646 53,542
Y / Y Investment Growth 1.99 % 14.27 % 12.58 % -3.54 % 3.46 %
Net Income in Millions 6,524 13,402 5,723 6,933 7,071
Y / Y Net Income Growth -51.32 % 134.18 % -17.45 % -1.95 % 57.31 %
Annual Return On Investment 9.63 % 20.17 % 9.84 % 13.42 % 13.21 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 9.63 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ABT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ABT's Competitors
Subscribers only: Roi for Abbott Laboratories's Suppliers
Subscribers only: Return On Investment for ABT's Customers

Other Ratios
ABT's Roa ABT's Inventory Turnover Ratio ABT's Growth Rates ABT's Dividend Statistics
ABT's Profitability Ratios ABT's Asset Turnover Ratio ABT's Dividend Growth
ABT's Roe ABT's Valuation Ratios ABT's Financial Strength Ratios ABT's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %
Bio rad Laboratories Inc   10.59 %
Lemaitre Vascular Inc   10.56 %
Johnson and Johnson  10.53 %
Encompass Health Corporation  10.41 %
Ani Pharmaceuticals Inc  9.61 %
Tactile Systems Technology Inc   9.27 %
Boston Scientific Corporation  9.14 %
Brightspring Health Services Inc   9.01 %
Stryker Corp  8.63 %
Pediatrix Medical Group Inc   8.37 %
Penumbra Inc  8.28 %
Medinotec Inc   8.12 %
Pacific Health Care Organization Inc  8.09 %
Quest Diagnostics Inc  8.01 %
Ge Healthcare Technologies Inc   7.60 %
Incyte Corporation  6.81 %
Merit Medical Systems Inc  6.21 %

Date modified: 2026-11-10T11:44:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.